SEC Form 4 · accession 0000882796-26-000065
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon P Stonehouse
Director
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2026 | A | 644 | $9.70 | A | 1,340,419 | D | |
| Common Stock | holding | — | — | — | 40,000 | I | By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust | |
| Common Stock | holding | — | — | — | 40,000 | I | By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500.